Metronomic chemotherapy and tumor immunomodulation

被引：2
作者：
Bernacki, Ralph J. [1 ]
机构：
[1] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA
来源：
CANCER BIOLOGY & THERAPY | 2008年 / 7卷 / 04期
关键词：
camptothecin; gimatecan; CpG-oligodeoxynucleotide; pancreatic cancer; TRAIL; animal models; metronomic chemotherapy;
D O I：
10.4161/cbt.7.4.5632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：602 / 602
页数：1
相关论文
共 6 条
[1]  
BROWDER T, 2000, CANCER RES, V60, P4143
[2]  
CHABNER BA, 1989, CANCER PRINCIPLES PR, V1, P349
[3]   Five years of clinical experience with metronomic chemotherapy: Achievements and perspectives [J].
Emmenegger, Urban ;
Kerbel, Robert S. .
ONKOLOGIE, 2007, 30 (12) :606-608
[4]   Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [J].
Hanahan, D ;
Bergers, G ;
Bergsland, E .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1045-1047
[5]   Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics [J].
Mihich, Enrico .
CURRENT CANCER THERAPY REVIEWS, 2007, 3 (03) :174-193
[6]  
STEINBILD S, 2007, ONKOLOGIE, V30
1